$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000168875720000044 Filed on August 07, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$10.47M	$21.68M
YoY Change	-51.7%	58.17%
Cost Of Revenue	$3.240M	$8.672M
YoY Change	-62.64%	57.9%
Gross Profit	$7.234M	$13.01M
YoY Change	-44.41%	58.35%
Gross Profit Margin	69.07%	60.01%
Selling, General & Admin	$14.44M	$18.39M
YoY Change	-21.51%	69.86%
% of Gross Profit	199.59%	141.36%
Research & Development	$2.399M	$4.001M
YoY Change	-40.04%	7.99%
% of Gross Profit	33.16%	30.75%
Depreciation & Amortization	$21.00K	$21.00K
YoY Change	0.0%	-12.5%
% of Gross Profit	0.29%	0.16%
Operating Expenses	$16.84M	$22.40M
YoY Change	-24.82%	54.09%
Operating Profit	-$9.603M	-$9.383M
YoY Change	2.34%	48.54%
Interest Expense	$2.130M	$2.521M
YoY Change	-15.51%	16.01%
% of Operating Profit
Other Income/Expense, Net	$102.0K	$118.0K
YoY Change	-13.56%	-105.47%
Pretax Income	-$10.28M	-$9.005M
YoY Change	14.14%	72.91%
Income Tax	$194.0K	$35.00K
% Of Pretax Income
Net Earnings	-$10.47M	-$9.040M
YoY Change	15.84%	68.66%
Net Earnings / Revenue	-99.98%	-41.69%
Basic Earnings Per Share	-$0.45
Diluted Earnings Per Share	-$0.45	-$442.1K
COMMON SHARES
Basic Shares Outstanding	23.48M shares	20.41M shares
Diluted Shares Outstanding	23.48M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$86.40M	$31.90M
YoY Change	170.85%	175.0%
Cash & Equivalents	$86.38M	$31.87M
Short-Term Investments
Other Short-Term Assets	$3.800M	$4.500M
YoY Change	-15.56%	4.65%
Inventory	$29.06M	$26.54M
Prepaid Expenses
Receivables	$17.14M	$21.31M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$136.4M	$84.18M
YoY Change	62.07%	85.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.09M	$16.71M
YoY Change	-3.73%	26.58%
Goodwill	$465.0K	$465.0K
YoY Change	0.0%
Intangibles	$3.480M	$3.081M
YoY Change	12.95%
Long-Term Investments
YoY Change
Other Assets	$360.0K	$370.0K
YoY Change	-2.7%	-66.36%
Total Long-Term Assets	$20.39M	$20.62M
YoY Change	-1.13%	14.58%
TOTAL ASSETS
Total Short-Term Assets	$136.4M	$84.18M
Total Long-Term Assets	$20.39M	$20.62M
Total Assets	$156.8M	$104.8M
YoY Change	49.63%	65.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.293M	$8.531M
YoY Change	-2.79%	13.75%
Accrued Expenses	$10.52M	$8.718M
YoY Change	20.64%	61.44%
Deferred Revenue	$728.0K	$751.0K
YoY Change	-3.06%
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$100.0K	$400.0K
YoY Change	-75.0%	33.33%
Total Short-Term Liabilities	$20.55M	$21.39M
YoY Change	-3.9%	13.76%
LONG-TERM LIABILITIES
Long-Term Debt	$48.94M	$24.10M
YoY Change	103.07%	16.43%
Other Long-Term Liabilities	$2.026M	$3.415M
YoY Change	-40.67%	-84.12%
Total Long-Term Liabilities	$50.97M	$3.415M
YoY Change	1392.39%	-91.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.55M	$21.39M
Total Long-Term Liabilities	$50.97M	$3.415M
Total Liabilities	$75.03M	$51.01M
YoY Change	47.07%	-16.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$155.4M	-$108.8M
YoY Change	42.8%
Common Stock	$211.9M	$146.4M
YoY Change	44.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.854M	$2.854M
YoY Change	0.0%
Treasury Stock Shares	408.1K shares	408.1K shares
Shareholders Equity	$81.79M	$53.79M
YoY Change
Total Liabilities & Shareholders Equity	$156.8M	$104.8M
YoY Change	49.63%	65.56%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	-$10.47M	-$9.040M
YoY Change	15.84%	68.66%
Depreciation, Depletion And Amortization	$21.00K	$21.00K
YoY Change	0.0%	-12.5%
Cash From Operating Activities	-$6.100M	-$7.060M
YoY Change	-13.6%	-21.38%
INVESTING ACTIVITIES
Capital Expenditures	-$840.0K	-$4.210M
YoY Change	-80.05%	1215.63%
Acquisitions
YoY Change
Other Investing Activities	-$500.0K	$0.00
YoY Change
Cash From Investing Activities	-$1.330M	-$4.210M
YoY Change	-68.41%	1215.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	110.0K	-20.00K
YoY Change	-650.0%	-100.14%
NET CHANGE
Cash From Operating Activities	-6.100M	-7.060M
Cash From Investing Activities	-1.330M	-4.210M
Cash From Financing Activities	110.0K	-20.00K
Net Change In Cash	-7.320M	-11.29M
YoY Change	-35.16%	-324.9%
FREE CASH FLOW
Cash From Operating Activities	-$6.100M	-$7.060M
Capital Expenditures	-$840.0K	-$4.210M
Free Cash Flow	-$5.260M	-$2.850M
YoY Change	84.56%	-67.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Country Region CountryRegion	506
	dei	City Area Code CityAreaCode	24
	dei	Local Phone Number LocalPhoneNumber	34 2400
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001688757
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Establishment Labs Holdings Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1289000	USD
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Coyol Free Zone
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Building B15 and 25
	dei	Entity Address City Or Town EntityAddressCityOrTown	Alajuela
	dei	Entity Address Country EntityAddressCountry	CR
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
	dei	Trading Symbol TradingSymbol	ESTA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23367033	shares
CY2020Q2	us-gaap	Cash Cash	86382000	USD
CY2019Q4	us-gaap	Cash Cash	37655000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1954000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1026000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17142000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22767000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	29057000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28660000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3841000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6757000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	136422000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	95839000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16085000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16418000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	465000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	465000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3480000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3441000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	360000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	368000	USD
CY2020Q2	us-gaap	Assets Assets	156812000	USD
CY2019Q4	us-gaap	Assets Assets	116531000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	8293000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10366000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10517000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10677000	USD
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1742000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2199000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20552000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23242000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48939000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48142000	USD
CY2020Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3509000	USD
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3072000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2026000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2461000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	75026000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	76917000	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23762787	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21057040	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23354717	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20648970	shares
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	211932000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	147688000	USD
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24338000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21214000	USD
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-155355000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127125000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3725000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	691000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	81786000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	39614000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	156812000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116531000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10474000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21684000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34955000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42462000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	3240000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	8672000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12243000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	18198000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	7234000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	13012000	USD
	us-gaap	Gross Profit GrossProfit	22712000	USD
	us-gaap	Gross Profit GrossProfit	24264000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14438000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18394000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	33422000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34450000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2399000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4001000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6598000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7585000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	16837000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	22395000	USD
	us-gaap	Operating Expenses OperatingExpenses	40020000	USD
	us-gaap	Operating Expenses OperatingExpenses	42035000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9603000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9383000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17308000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17771000	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	USD
CY2019Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	2130000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	2521000	USD
	us-gaap	Interest Expense InterestExpense	4276000	USD
	us-gaap	Interest Expense InterestExpense	4763000	USD
CY2020Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1492000	USD
CY2019Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2640000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-437000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2608000	USD
CY2020Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	141000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-137000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-299000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-362000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	103000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	118000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6093000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-186000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10277000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9005000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27805000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19740000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	194000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	425000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	79000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10471000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-9040000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-28230000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19819000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.23
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.97
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23482031	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20448643	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22969162	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20407912	shares
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10471000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-9040000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-28230000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19819000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	213000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-154000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3034000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-87000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	213000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-154000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3034000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-87000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10258000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9194000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25196000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19906000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	39614000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	181000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1629000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	34000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2821000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-17759000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	90307000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	193000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1557000	USD
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	213000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10471000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	81786000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	69485000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	337000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	84000	USD
CY2019Q1	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	56000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1836000	USD
CY2019Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	56000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	67000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-10779000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	61030000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	92000	USD
CY2019Q2	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	0	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1894000	USD
CY2019Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	35000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-154000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-9040000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	53787000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-28230000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19819000	USD
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	1629000	USD
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	1416000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	971000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-17000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	564000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-22000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3186000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3730000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-114000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-24000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-5647000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-67000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-437000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2608000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-299000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-362000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	797000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1731000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4150000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3715000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3235000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	725000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2667000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	234000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-4000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	56000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2413000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2709000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	407000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12897000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15061000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1290000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4882000	USD
	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	497000	USD
	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	767000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	495000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2282000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5666000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	139000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	185000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	63855000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	374000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	176000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	58000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	48000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	91000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64042000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-42000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-136000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48727000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20769000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37655000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52639000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86382000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31870000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3464000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	146000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	327000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2724000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	622000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	69000	USD
	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	0	USD
	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	337000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	1257000	USD
	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	779000	USD
	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	1277000	USD
CY2020Q2	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-top:6.25pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">estimates and management judgments reflected in the condensed </span><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets’ useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:6.25pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institutions in the United States. Balances in the Company’s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2020 and 2019, no customers accounted for more than 10% of the Company’s revenue. Substantially all of the Company’s revenues are derived from the sale of Motiva Implants. One customer accounted for 13.0% and another customer accounted for 11.5% of the Company’s trade accounts receivable balance as of June 30, 2020. One customer accounted for 10.2% of the Company’s trade accounts receivable balance as of </span><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December 31, 2019</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company relies on NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the six months ended June 30, 2020 and 2019, the Company had purchases of $8.1 million, or 67.4% of total purchases, and $8.1 million, or 62.1% of total purchases, respectively, from NuSil. As of June 30, 2020 and </span><span style="background-color:rgb(255,255,255, 0.0);color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December 31, 2019</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, the Company had an outstanding balance owed to this vendor of $2.0 million and $2.7 million, respectively.</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </span></div>Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.
CY2020Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2020Q2	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	600000	USD
CY2020Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	900000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000	USD
	esta	Revenue From Contract With Customer Product Return Period RevenueFromContractWithCustomerProductReturnPeriod	P15D
CY2020Q2	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	24000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	36000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34955000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42462000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10474000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21684000	USD
	esta	Revenue From Contract With Customer Product Shelf Life RevenueFromContractWithCustomerProductShelfLife	P5Y
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P50Y
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="margin-top:6pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Debt and Embedded Derivatives</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Debt with Conversion and Other Options</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (see Note 6).</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note 5).</span></div>
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1200000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5800000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-300000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8470000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7522000	USD
CY2020Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6510000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5506000	USD
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1265000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1200000	USD
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21282000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21954000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	29057000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28660000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24555000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23940000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16085000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16418000	USD
CY2019Q2	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	700000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1300000	USD
CY2020Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1500000	USD
CY2019Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1500000	USD
CY2019Q2	us-gaap	Depreciation Depreciation	21000	USD
	us-gaap	Depreciation Depreciation	42000	USD
CY2020Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1148000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2080000	USD
CY2020Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2702000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1996000	USD
CY2020Q2	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	5102000	USD
CY2019Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	4212000	USD
CY2020Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	246000	USD
CY2019Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	522000	USD
CY2020Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	494000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	500000	USD
CY2020Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	118000	USD
CY2019Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	258000	USD
CY2020Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	264000	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	313000	USD
CY2020Q2	esta	Advisory Board And Board Of Director Liabilities Current AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent	3000	USD
CY2019Q4	esta	Advisory Board And Board Of Director Liabilities Current AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent	124000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	440000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	672000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10517000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10677000	USD
CY2020Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	623000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	922000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	728000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	785000	USD
CY2020Q2	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	391000	USD
CY2019Q4	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	492000	USD
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1742000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2199000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1290000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1344000	USD
CY2020Q2	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	388000	USD
CY2019Q4	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	781000	USD
CY2020Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	348000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3480000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	336000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2026000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2461000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	465000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q2	us-gaap	Goodwill Goodwill	465000	USD
CY2020Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2020Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2020Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5839000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2359000	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5364000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1923000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3441000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	509000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	910000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	585000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	340000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	324000	USD
CY2020Q2	esta	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	521000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3189000	USD
CY2020Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
CY2019Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	500000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	284000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	483000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	413000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	381000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	373000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1179000	USD
CY2020Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3113000	USD
CY2020Q2	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	129000	USD
CY2020Q2	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	180000	USD
CY2020Q2	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	39000	USD
CY2020Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	348000	USD
CY2020Q2	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	22000	USD
CY2020Q2	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	326000	USD
CY2020Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	118000	USD
CY2020Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	208000	USD
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23762787	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21057040	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23354717	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20648970	shares
CY2020Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4357937	shares
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3571406	shares
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1557000	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1894000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3186000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3730000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1837576	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.54
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y21D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	24122000	USD
CY2020Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8400000	USD
	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P2Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	367265	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	19.11
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	62457	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	97750	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	15.70
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2044634	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.57
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y14D
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10046000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	835046	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.98
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	8000000.0	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	62457	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	800000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10471000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-9040000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-28230000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19819000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23482031	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20448643	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22969162	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20407912	shares
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.23
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.97
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2004244	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2073671	shares

Files In Submission

Name	View Source	Status
0001688757-20-000044-index-headers.html	Edgar Link	pending
0001688757-20-000044-index.html	Edgar Link	pending
0001688757-20-000044.txt	Edgar Link	pending
0001688757-20-000044-xbrl.zip	Edgar Link	pending
esta-20200630.htm	Edgar Link	pending
esta-20200630.xsd	Edgar Link	pending
esta-20200630_cal.xml	Edgar Link	unprocessable
esta-20200630_def.xml	Edgar Link	unprocessable
esta-20200630_htm.xml	Edgar Link	completed
esta-20200630_lab.xml	Edgar Link	unprocessable
esta-20200630_pre.xml	Edgar Link	unprocessable
ex101executedmadrynfo344.htm	Edgar Link	pending
ex101executedmadrynfo344001.jpg	Edgar Link	pending
ex101executedmadrynfo344002.jpg	Edgar Link	pending
ex101executedmadrynfo344003.jpg	Edgar Link	pending
ex101executedmadrynfo344004.jpg	Edgar Link	pending
ex101executedmadrynfo344005.jpg	Edgar Link	pending
ex101executedmadrynfo344006.jpg	Edgar Link	pending
ex101executedmadrynfo344007.jpg	Edgar Link	pending
ex101executedmadrynfo344008.jpg	Edgar Link	pending
ex101executedmadrynfo344009.jpg	Edgar Link	pending
ex101executedmadrynfo344010.jpg	Edgar Link	pending
ex101executedmadrynfo344011.jpg	Edgar Link	pending
ex101executedmadrynfo344012.jpg	Edgar Link	pending
ex101executedmadrynfo344013.jpg	Edgar Link	pending
ex101executedmadrynfo344014.jpg	Edgar Link	pending
ex101executedmadrynfo344015.jpg	Edgar Link	pending
ex101executedmadrynfo344016.jpg	Edgar Link	pending
ex101executedmadrynfo344017.jpg	Edgar Link	pending
ex101executedmadrynfo344018.jpg	Edgar Link	pending
ex101executedmadrynfo344019.jpg	Edgar Link	pending
ex101executedmadrynfo344020.jpg	Edgar Link	pending
ex101executedmadrynfo344021.jpg	Edgar Link	pending
ex101executedmadrynfo344022.jpg	Edgar Link	pending
ex101executedmadrynfo344023.jpg	Edgar Link	pending
ex101executedmadrynfo344024.jpg	Edgar Link	pending
ex101executedmadrynfo344025.jpg	Edgar Link	pending
ex101executedmadrynfo344026.jpg	Edgar Link	pending
ex101executedmadrynfo344027.jpg	Edgar Link	pending
ex101executedmadrynfo344028.jpg	Edgar Link	pending
ex101executedmadrynfo344029.jpg	Edgar Link	pending
ex101executedmadrynfo344030.jpg	Edgar Link	pending
ex101executedmadrynfo344031.jpg	Edgar Link	pending
ex101executedmadrynfo344032.jpg	Edgar Link	pending
ex101executedmadrynfo344033.jpg	Edgar Link	pending
ex101executedmadrynfo344034.jpg	Edgar Link	pending
ex101executedmadrynfo344035.jpg	Edgar Link	pending
ex101executedmadrynfo344036.jpg	Edgar Link	pending
ex101executedmadrynfo344037.jpg	Edgar Link	pending
ex101executedmadrynfo344038.jpg	Edgar Link	pending
ex101executedmadrynfo344039.jpg	Edgar Link	pending
ex101executedmadrynfo344040.jpg	Edgar Link	pending
ex101executedmadrynfo344041.jpg	Edgar Link	pending
ex101executedmadrynfo344042.jpg	Edgar Link	pending
ex101executedmadrynfo344043.jpg	Edgar Link	pending
ex101executedmadrynfo344044.jpg	Edgar Link	pending
ex101executedmadrynfo344045.jpg	Edgar Link	pending
ex101executedmadrynfo344046.jpg	Edgar Link	pending
ex101executedmadrynfo344047.jpg	Edgar Link	pending
ex101executedmadrynfo344048.jpg	Edgar Link	pending
ex101executedmadrynfo344049.jpg	Edgar Link	pending
ex101executedmadrynfo344050.jpg	Edgar Link	pending
ex101executedmadrynfo344051.jpg	Edgar Link	pending
ex101executedmadrynfo344052.jpg	Edgar Link	pending
ex101executedmadrynfo344053.jpg	Edgar Link	pending
ex101executedmadrynfo344054.jpg	Edgar Link	pending
ex101executedmadrynfo344055.jpg	Edgar Link	pending
ex101executedmadrynfo344056.jpg	Edgar Link	pending
ex101executedmadrynfo344057.jpg	Edgar Link	pending
ex101executedmadrynfo344058.jpg	Edgar Link	pending
ex101executedmadrynfo344059.jpg	Edgar Link	pending
ex101executedmadrynfo344060.jpg	Edgar Link	pending
ex101executedmadrynfo344061.jpg	Edgar Link	pending
ex101executedmadrynfo344062.jpg	Edgar Link	pending
ex101executedmadrynfo344063.jpg	Edgar Link	pending
ex101executedmadrynfo344064.jpg	Edgar Link	pending
ex101executedmadrynfo344065.jpg	Edgar Link	pending
ex101executedmadrynfo344066.jpg	Edgar Link	pending
ex101executedmadrynfo344067.jpg	Edgar Link	pending
ex101executedmadrynfo344068.jpg	Edgar Link	pending
ex101executedmadrynfo344069.jpg	Edgar Link	pending
ex101executedmadrynfo344070.jpg	Edgar Link	pending
ex101executedmadrynfo344071.jpg	Edgar Link	pending
ex101executedmadrynfo344072.jpg	Edgar Link	pending
ex101executedmadrynfo344073.jpg	Edgar Link	pending
ex101executedmadrynfo344074.jpg	Edgar Link	pending
ex101executedmadrynfo344075.jpg	Edgar Link	pending
ex101executedmadrynfo344076.jpg	Edgar Link	pending
ex101executedmadrynfo344077.jpg	Edgar Link	pending
ex101executedmadrynfo344078.jpg	Edgar Link	pending
ex101executedmadrynfo344079.jpg	Edgar Link	pending
ex101executedmadrynfo344080.jpg	Edgar Link	pending
ex101executedmadrynfo344081.jpg	Edgar Link	pending
ex101executedmadrynfo344082.jpg	Edgar Link	pending
ex101executedmadrynfo344083.jpg	Edgar Link	pending
ex101executedmadrynfo344084.jpg	Edgar Link	pending
ex101executedmadrynfo344085.jpg	Edgar Link	pending
ex101executedmadrynfo344086.jpg	Edgar Link	pending
ex101executedmadrynfo344087.jpg	Edgar Link	pending
ex101executedmadrynfo344088.jpg	Edgar Link	pending
ex101executedmadrynfo344089.jpg	Edgar Link	pending
ex101executedmadrynfo344090.jpg	Edgar Link	pending
ex101executedmadrynfo344091.jpg	Edgar Link	pending
ex101executedmadrynfo344092.jpg	Edgar Link	pending
ex101executedmadrynfo344093.jpg	Edgar Link	pending
ex101executedmadrynfo344094.jpg	Edgar Link	pending
ex101executedmadrynfo344095.jpg	Edgar Link	pending
ex101executedmadrynfo344096.jpg	Edgar Link	pending
ex101executedmadrynfo344097.jpg	Edgar Link	pending
ex101executedmadrynfo344098.jpg	Edgar Link	pending
ex101executedmadrynfo344099.jpg	Edgar Link	pending
ex101executedmadrynfo344100.jpg	Edgar Link	pending
ex101executedmadrynfo344101.jpg	Edgar Link	pending
ex101executedmadrynfo344102.jpg	Edgar Link	pending
ex101executedmadrynfo344103.jpg	Edgar Link	pending
ex101executedmadrynfo344104.jpg	Edgar Link	pending
ex101executedmadrynfo344105.jpg	Edgar Link	pending
ex101executedmadrynfo344106.jpg	Edgar Link	pending
ex101executedmadrynfo344107.jpg	Edgar Link	pending
ex101executedmadrynfo344108.jpg	Edgar Link	pending
ex101executedmadrynfo344109.jpg	Edgar Link	pending
ex101executedmadrynfo344110.jpg	Edgar Link	pending
ex101executedmadrynfo344111.jpg	Edgar Link	pending
ex101executedmadrynfo344112.jpg	Edgar Link	pending
ex101executedmadrynfo344113.jpg	Edgar Link	pending
ex101executedmadrynfo344114.jpg	Edgar Link	pending
ex101executedmadrynfo344115.jpg	Edgar Link	pending
ex101executedmadrynfo344116.jpg	Edgar Link	pending
ex101executedmadrynfo344117.jpg	Edgar Link	pending
ex101executedmadrynfo344118.jpg	Edgar Link	pending
ex101executedmadrynfo344119.jpg	Edgar Link	pending
ex101executedmadrynfo344120.jpg	Edgar Link	pending
ex101executedmadrynfo344121.jpg	Edgar Link	pending
ex101executedmadrynfo344122.jpg	Edgar Link	pending
ex101executedmadrynfo344123.jpg	Edgar Link	pending
ex101executedmadrynfo344124.jpg	Edgar Link	pending
ex101executedmadrynfo344125.jpg	Edgar Link	pending
ex101executedmadrynfo344126.jpg	Edgar Link	pending
ex101executedmadrynfo344127.jpg	Edgar Link	pending
ex101executedmadrynfo344128.jpg	Edgar Link	pending
ex101executedmadrynfo344129.jpg	Edgar Link	pending
ex101executedmadrynfo344130.jpg	Edgar Link	pending
ex101executedmadrynfo344131.jpg	Edgar Link	pending
ex101executedmadrynfo344132.jpg	Edgar Link	pending
ex101executedmadrynfo344133.jpg	Edgar Link	pending
ex101executedmadrynfo344134.jpg	Edgar Link	pending
ex101executedmadrynfo344135.jpg	Edgar Link	pending
ex101executedmadrynfo344136.jpg	Edgar Link	pending
ex101executedmadrynfo344137.jpg	Edgar Link	pending
ex101executedmadrynfo344138.jpg	Edgar Link	pending
ex101executedmadrynfo344139.jpg	Edgar Link	pending
ex101executedmadrynfo344140.jpg	Edgar Link	pending
ex101executedmadrynfo344141.jpg	Edgar Link	pending
ex101executedmadrynfo344142.jpg	Edgar Link	pending
ex101executedmadrynfo344143.jpg	Edgar Link	pending
ex101executedmadrynfo344144.jpg	Edgar Link	pending
ex101executedmadrynfo344145.jpg	Edgar Link	pending
ex101executedmadrynfo344146.jpg	Edgar Link	pending
ex101executedmadrynfo344147.jpg	Edgar Link	pending
ex101executedmadrynfo344148.jpg	Edgar Link	pending
ex101executedmadrynfo344149.jpg	Edgar Link	pending
ex101executedmadrynfo344150.jpg	Edgar Link	pending
ex101executedmadrynfo344151.jpg	Edgar Link	pending
ex101executedmadrynfo344152.jpg	Edgar Link	pending
ex101executedmadrynfo344153.jpg	Edgar Link	pending
ex101executedmadrynfo344154.jpg	Edgar Link	pending
ex101executedmadrynfo344155.jpg	Edgar Link	pending
ex101executedmadrynfo344156.jpg	Edgar Link	pending
ex101executedmadrynfo344157.jpg	Edgar Link	pending
ex101executedmadrynfo344158.jpg	Edgar Link	pending
ex101executedmadrynfo344159.jpg	Edgar Link	pending
ex101executedmadrynfo344160.jpg	Edgar Link	pending
ex101executedmadrynfo344161.jpg	Edgar Link	pending
ex101executedmadrynfo344162.jpg	Edgar Link	pending
ex101executedmadrynfo344163.jpg	Edgar Link	pending
ex101executedmadrynfo344164.jpg	Edgar Link	pending
ex101executedmadrynfo344165.jpg	Edgar Link	pending
ex101executedmadrynfo344166.jpg	Edgar Link	pending
ex101executedmadrynfo344167.jpg	Edgar Link	pending
ex101executedmadrynfo344168.jpg	Edgar Link	pending
ex101executedmadrynfo344169.jpg	Edgar Link	pending
ex101executedmadrynfo344170.jpg	Edgar Link	pending
ex101executedmadrynfo344171.jpg	Edgar Link	pending
ex101executedmadrynfo344172.jpg	Edgar Link	pending
exhibit311q22020.htm	Edgar Link	pending
exhibit312q22020.htm	Edgar Link	pending
exhibit321q22020.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2020 Q2 Form 10-Q Financial Statement

#000168875720000044 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2020 Q2 Form 10-Q Financial Statement

#000168875720000044 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta